You are investing in knowledge that can significantly improve the wellbeing of a group of people that you may not know.

Federal cuts to research have had real-world effects. But for one Yale researcher, the work has continued with alternative ...

SDLC guides teams to plan, build, test, and deliver software. Discover phases, KPIs, tools, and checklist with our quick start guide. Picture this: You and your team have spent a tremendous amount of ...

For the sixth year in a row Arkansas has been named the "Most Pro-Life State" in the nation by Americans United for Life. Making the announcement at the state Capitol on Monday, Sarah Zagorski, a ...

Marshall Hargrave is a stock analyst and writer with 10+ years of experience covering stocks and markets, as well as analyzing and valuing companies. Khadija Khartit is a strategy, investment, and ...

Strategic CRO to Support Path to Phase 2/3 Trials Following Recently Demonstrated Groundbreaking 97% Inhibition Rates for SIL204 Phase 2/3 Clinical Trials Expected to Commence in First Half of 2026 ...

SELLAS Life Sciences is developing GPS as a WT1 immunotherapy, which is in Phase 3 for AML. However, I believe their SLS009 candidate as a CDK9 inhibitor further gives the stock broad AML ...

The authors do not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and have disclosed no relevant affiliations beyond their ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Use of alternative endpoints in phase 3 oncology trials ...

Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. As a business leader, you likely recognize the enduring truth: Change is the only constant.

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min IMA Life hasn't even finished ...